Off-market insider buying at PharmaCielo (PCLO)

Off-market insider buying at PharmaCielo (V:PCLO)

Marc Lustig, a Director, acquired 95,577 Common Shares on a direct ownership basis at a price of $0.192 through a prospectus or prospectus exempt offering on January 8th, 2024. The insider also acquired 501,364 Common Shares on an indirect ownership basis for registered holder L5 Capital Inc. at a price of $0.192 through a prospectus or prospectus exempt offering on January 8th, 2024. This represents a $114,911 investment into the company's shares and an account share holdings change of 15.3%.

William Boris Petron, CEO and Director, acquired 322,308 Common Shares on a direct ownership basis at a price of $0.192 through a prospectus or prospectus exempt offering on January 8th, 2024. This represents a $62,044 investment into the company's shares and an account share holdings change of 8.5%.

Ian D. Atacan, CFO and Director, acquired 57,298 Common Shares on a direct ownership basis at a price of $0.192 through a prospectus or prospectus exempt offering on January 8th, 2024. This represents a $11,030 investment into the company's shares and an account share holdings change of 10.5%.

PharmaCielo is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

PharmaCielo Ltd. is a Canada-based company with a focus on ethical and sustainable processing and supplying of all natural, pharmaceutical-grade medical cannabis products to channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company's all-natural cannabis into standardized, medicinal-grade oil extracts and related products. In Colombia, PharmaCielo Colombia is a licensed cultivator, producer, and distributor of both TetraHydroCannabinol (THC) and Cannabidiol (CBD) medical cannabis for use in Colombia, international export, and research purposes. Ubiquo is a knowledge management and medical consultation system that focuses on creating access to healthcare for Colombians. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate. Ubiquo is used as a communication tool.